DUBLIN--(BUSINESS WIRE)--

Research and Markets (http://www.researchandmarkets.com/research/pgsg7h/spinocerebellar_at) has announced the addition of Global Markets Direct's new report "Spinocerebellar Ataxias - Pipeline Review, H1 2012" to their offering.

Global Markets Direct's, 'Spinocerebellar Ataxias - Pipeline Review, H1 2012', provides an overview of the Spinocerebellar Ataxias therapeutic pipeline. This report provides information on the therapeutic development for Spinocerebellar Ataxias, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Spinocerebellar Ataxias. 'Spinocerebellar Ataxias - Pipeline Review, H1 2012' is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Scope

- A snapshot of the global therapeutic scenario for Spinocerebellar Ataxias.

- A review of the Spinocerebellar Ataxias products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.

- Coverage of products based on various stages of development ranging from discovery till registration stages.

- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.

- Coverage of the Spinocerebellar Ataxias pipeline on the basis of route of administration and molecule type.

- Profiles of late-stage pipeline products featuring sections on product description, mechanism of action and research & development progress.

See the original post here:
Research and Markets: Spinocerebellar Ataxias - Pipeline Review, H1 2012